Pigmentary disorders in India.
This article addresses pigmentary disorders relevant to India. Many of these disorders are easily spotted because of the Indians' darker complexion. The authors examine hypopigmentary and hyperpigmentary disorders, defining the main characteristics of each and their relevance to the people of India, including social as well as physical ramifications. The authors propose the treatments available to Indians exhibiting these skin disorders.
Pasricha
J S
JS
Skin Diseases Centre, 1-A, Masjid Moth, DDA Flats, Phase-I, Outer Ring Road, Near Cirag Delhi, Flyover, New Delhi 110048, India. j_s_pasricha@hotmail.com
Khaitan
Binod K
BK
Dash
Sushrute
S
D000686:Amyloidosis / Q000145:classification; D003872:Dermatitis / Q000145:classification; D017484:Dermatitis, Phototoxic / Q000145:classification / Q000517:prevention & control; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007194:India; D007978:Levamisole / Q000627:therapeutic use; D008548:Melanosis / Q000145:classification / Q000628:therapy; D009507:Nevus of Ota / Q000145:classification; D010778:Photochemotherapy; D010859:Pigmentation Disorders / Q000145:classification* / Q000628:therapy; D010915:Pityriasis / Q000145:classification / Q000628:therapy; D012878:Skin Neoplasms / Q000145:classification; D013472:Sunlight / Q000009:adverse effects; D014820:Vitiligo / Q000145:classification / Q000188:drug therapy
D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D007978:Levamisole